Brief: Rallybio Corporation And Candid Therapeutics Announce Merger Agreement

Rallybio

02/03/2026 13:25

March 2 (Reuters) - Rallybio Corp RLYB.O:

RALLYBIO CORPORATION AND CANDID THERAPEUTICS ANNOUNCE MERGER AGREEMENT

RALLYBIO CORP - COMBINED COMPANY TO OPERATE AS CANDID THERAPEUTICS UNDER TICKER CDRX

RALLYBIO CORP - COMBINED COMPANY'S CASH EXPECTED TO FUND OPERATIONS THROUGH 2030

RALLYBIO CORP - CANDID SECURES OVERSUBSCRIBED AND UPSIZED PRIVATE FINANCING OF OVER $505 MILLION IN GROSS PROCEEDS

RALLYBIO CORP - CO'S EQUITYHOLDERS TO OWN 3.65% OF COMBINED COMPANY

RALLYBIO CORP - PRE-TRANSACTION CANDID EQUITYHOLDERS EXPECTED TO OWN ABOUT 96.35% OF COMBINED CO

Source text: ID:nBwprJ7La

Further company coverage: RLYB.O

 ((Reuters.Briefs@thomsonreuters.com;))